ALEC MEXC RealStocks
Own real ALEC shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1

Last updated: 2026-11-19 21:07:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Alector, Inc. (ALEC) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $2.31, with a market capitalization of $381.13M and a P/E ratio of 9.26. Over the past 52 weeks, its price has ranged from $1.09 to $2.84. This page covers its latest market performance, valuation, price trends and company information.
$381.13M | |
$2.50 | |
$2.63 | |
$2.30 | |
$2.57 | |
1.44M | |
3.35M | |
9.26 | |
$2.84 | |
$1.09 | |
-- | |
2026-09-30 |
Alector, Inc. (ALEC) is trading at $2.30 in after-hours trading as of 2026-11-19 20:50:52, down 0.22% ($0.01) from the regular-session close of $2.31.
After-hours trading shows how investors are pricing ALEC after the regular session closes. The current after-hours price is near the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Alector, Inc. (ALEC) moved from $2.53 to $2.31, representing a decline of 8.89% ($0.22).
The stock traded between $2.30 and $2.84 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.37 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 69.4%
ALEC is currently trading at $2.31, placing it 69.4% of the way from its 52-week low of $1.09 to its 52-week high of $2.84. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 103 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Alector, Inc. (ALEC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ALEC, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ALEC shares and USD.
ALEC Shares to USD
1.00 ALEC shares = 2.305 USD
Calculations are estimates based on the latest available price and are for reference only.